1,2,3,6-tetrahydropyrimidine-2-one compositions, articles and therapeutic methods for upper airway breathing disorders
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61K-031/513
A61K-038/18
A61K-031/47
C07D-241/40
C07D-215/16
출원번호
US-0267896
(2002-10-08)
발명자
/ 주소
Wei, Edward T.
인용정보
피인용 횟수 :
0인용 특허 :
17
초록▼
A therapeutic composition is provided that comprises a 1-R1-phenyl, 4-R2-phenyl substituted 1,2,3,6-tetrahydropyrimidine-2-one cold receptor agonist in a therapeutically effective amount. The cold receptor agonist may be represented by the general formula 1-[R1-phenyl]-4-[R2-phenyl]-1,2,3,6-tetrahyd
A therapeutic composition is provided that comprises a 1-R1-phenyl, 4-R2-phenyl substituted 1,2,3,6-tetrahydropyrimidine-2-one cold receptor agonist in a therapeutically effective amount. The cold receptor agonist may be represented by the general formula 1-[R1-phenyl]-4-[R2-phenyl]-1,2,3,6-tetrahydropyrimidine-2-one wherein: R1 is -hydroxy, -chloro, -fluoro, -alkyl, -acetoxy, -trifluoromethyl; and R2 is -nitro, -chloro, -fluoro, -alkyl, -trifluoromethyl. Therapeutic compositions of the invention when formulated for delivery to the mucous membranes of the nose and throat alleviate the sensations of airway obstruction and provide symptomatic relief of upper airway breathing disorders.
대표청구항▼
1. A method of treating airway obstruction in a mammalian patient comprising: administering via the nose or throat a therapeutically effective amount of a cold receptor agonist having the formula 1-[R1-phenyl]-4-[R2-phenyl]-1,2,3,6-tetrahydropyrimidine-2-one wherein R1 is hydroxy, chloro, fluoro, an
1. A method of treating airway obstruction in a mammalian patient comprising: administering via the nose or throat a therapeutically effective amount of a cold receptor agonist having the formula 1-[R1-phenyl]-4-[R2-phenyl]-1,2,3,6-tetrahydropyrimidine-2-one wherein R1 is hydroxy, chloro, fluoro, an alkyl of about 2 to about 4 carbon atoms, acetoxy, or trifluoromethyl and R2 is nitro, chloro, fluoro, an alkyl of about 2 to 4 carbon atoms or trifluoromethyl.2. The method as in claim 1 wherein the agonist is administered by inhalation as a powder.3. The method as in claim 1 wherein the administering includes flowing the agonist through the air as particles or droplets and into contact with the patient's upper airway.4. The method as in claim 1 wherein the agonist administered further includes an agent selected from the group consisting of an anti-inflammatory glucocorticosteroid, a local anesthetic, a sympathomimetic amine decongestant, an anti-histamine, a local anesthetic, menthol or a menthol analog and mixtures thereof.5. The method as in claim 2 wherein the agonist is administered in an amount of at least about 1 mg per application.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (17)
Wei, Edward T., 1,2,3,6-tetrahydropyrimidine-2-one compositions and therapeutic methods therewith for pain and inflammation.
Raja G. Achari ; Shamim Ahmed ; Charanjit R. Behl ; Jorge C. deMeireles ; Tianquing Liu ; Vincent D. Romeo ; Anthony P. Sileno, Nasal delivery of apomorphine.
Alfred P. Spada ; Wei He ; Michael R. Myers, Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases.
He Wei ; Myers Michael R. ; Spada Alfred P., Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.